Your browser doesn't support javascript.
loading
[Successful use of long-term follow-up in patients with chronic myeloid leukemia with a deep molecular response at reduced doses of 2nd generation tyrosine kinase inhibitors: clinical cases and literature review].
Gurianova, M A; Chelysheva, E Y; Shukhov, O A; Turkina, A G.
Affiliation
  • Gurianova MA; National Research Center for Hematology.
  • Chelysheva EY; National Research Center for Hematology.
  • Shukhov OA; National Research Center for Hematology.
  • Turkina AG; National Research Center for Hematology.
Ter Arkh ; 92(7): 90-94, 2020 Sep 01.
Article in Ru | MEDLINE | ID: mdl-33346450
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Protein Kinase Inhibitors Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Ru Journal: Ter Arkh Year: 2020 Document type: Article Country of publication: RUSSIA
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Protein Kinase Inhibitors Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Ru Journal: Ter Arkh Year: 2020 Document type: Article Country of publication: RUSSIA